OBJECTIVE: To justify the use of African mistletoe (AM) Viscum album (V. album) in folkoric medicine to treat diabetes. METHODS: In one experiment, the fasting blood glucose (FBG) levels of diabetic rats were monitored for 4 h. Diabetic rats were treated with AM at doses of 50 mg/kg (AM1) and 100 mg/kg (AM2), glibenclamide (GB) (positive control) and saline solution (SS). In another experiment, diabetic rats were treated with AM2, GB and SS daily for 3 weeks. RESULTS: AM1 and AM2 elicited significant (P<0.05) hypoglycaemic effects within 4 h of extract administration. AM1 and AM2 decreased the FBG by 41% and 49%, respectively, at 2 h. AM2 was found to lower FBG by 51%, relative to baseline, which was comparable to GB at 3 h. In the second experiment, AM2 and GB significantly (P<0.05) decreased the FBG by 34% and 51%, respectively. This was followed by marked decrease in levels of HbA1C in AM2- and GB- treated diabetic rats. AM2 significantly (P<0.05) decreased the STZ-induced increase in levels of serum triglyceride, urea, lactate dehydrogenase, α-amylase and low-density lipoprotein-cholesterol. Furthermore, diabetic rats treated with AM2 had significantly (P<0.05) elevated high-density lipoprotein-cholesterol. In contrast, STZ administration produced insignificant (P<0.05) effect on the levels of serum creatinine and total bilirubin. CONCLUSIONS: Extract of African mistletoe has anti-diabetic and anti-hyperlipidemic effects in STZ-diabetic rats. AM may find clinical application in the amelioration of diabetes-induced lipid disorders.
OBJECTIVE: To justify the use of African mistletoe (AM) Viscum album (V. album) in folkoric medicine to treat diabetes. METHODS: In one experiment, the fasting blood glucose (FBG) levels of diabeticrats were monitored for 4 h. Diabeticrats were treated with AM at doses of 50 mg/kg (AM1) and 100 mg/kg (AM2), glibenclamide (GB) (positive control) and saline solution (SS). In another experiment, diabeticrats were treated with AM2, GB and SS daily for 3 weeks. RESULTS: AM1 and AM2 elicited significant (P<0.05) hypoglycaemic effects within 4 h of extract administration. AM1 and AM2 decreased the FBG by 41% and 49%, respectively, at 2 h. AM2 was found to lower FBG by 51%, relative to baseline, which was comparable to GB at 3 h. In the second experiment, AM2 and GB significantly (P<0.05) decreased the FBG by 34% and 51%, respectively. This was followed by marked decrease in levels of HbA1C in AM2- and GB- treated diabeticrats. AM2 significantly (P<0.05) decreased the STZ-induced increase in levels of serum triglyceride, urea, lactate dehydrogenase, α-amylase and low-density lipoprotein-cholesterol. Furthermore, diabeticrats treated with AM2 had significantly (P<0.05) elevated high-density lipoprotein-cholesterol. In contrast, STZ administration produced insignificant (P<0.05) effect on the levels of serum creatinine and total bilirubin. CONCLUSIONS: Extract of African mistletoe has anti-diabetic and anti-hyperlipidemic effects in STZ-diabeticrats. AM may find clinical application in the amelioration of diabetes-induced lipid disorders.
Authors: Min Jung Kim; Jong-Heum Park; Dae Young Kwon; Hye Jeong Yang; Da Sol Kim; Suna Kang; Bae Keun Shin; Na Rang Moon; Beom-Seok Song; Jae-Hun Kim; Sunmin Park Journal: Exp Biol Med (Maywood) Date: 2014-09-25
Authors: Megan L Steele; Jan Axtner; Antje Happe; Matthias Kröz; Harald Matthes; Friedemann Schad Journal: Evid Based Complement Alternat Med Date: 2014-01-19 Impact factor: 2.629
Authors: P Balaji; R Madhanraj; K Rameshkumar; V Veeramanikandan; M Eyini; A Arun; Boobalan Thulasinathan; D A Al Farraj; M S Elshikh; A M Alokda; A H Mahmoud; J-C Tack; H-J Kim Journal: Saudi J Biol Sci Date: 2020-01-31 Impact factor: 4.219
Authors: Byoung-Seob Ko; Suna Kang; Bo Reum Moon; Jin Ah Ryuk; Sunmin Park Journal: Evid Based Complement Alternat Med Date: 2016-01-14 Impact factor: 2.629